Quick Answer
KYNTRA BIO, INC. reported Earnings Per Share Diluted of $45.37 per share for the year ending 2025.
- KYNTRA BIO, INC. showed an increase of +481.6% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from KYNTRA BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $0.58 per share | Q2 2015: $0.83 per share | Q2 2016: $0.35 per share | Q2 2017: $0.48 (loss) per share | Q2 2018: $0.28 (loss) per share | Q3 2018: $0.50 (loss) per share | Q2 2019: $1.26 per share | Q3 2019: $0.57 (loss) per share | Q2 2020: $0.95 (loss) per share | Q3 2020: $0.35 per share | Q2 2021: $1.45 (loss) per share | Q3 2021: $0.54 per share | Q1 2022: $0.68 (loss) per share | Q2 2022: $0.78 (loss) per share | Q3 2022: $0.98 (loss) per share | Q1 2023: $0.81 (loss) per share | Q2 2023: $0.90 (loss) per share | Q3 2023: $0.65 (loss) per share | Q1 2024: $0.33 (loss) per share | Q2 2024: $3.89 (loss) per share | Q3 2024: $4.25 (loss) per share | Q1 2025: $0.05 per share | Q2 2025: $1.88 (loss) per share | Q3 2025: $49.61 per share.
- Over the full 6 years of available data (2020 to 2025), KYNTRA BIO, INC.'s Earnings Per Share Diluted has grown by 2,250.2%.
- Historical annual values: Fiscal year 2025: $45.37 per share | Fiscal year 2024: $11.89 (loss) per share | Fiscal year 2023: $2.92 (loss) per share | Fiscal year 2022: $3.14 (loss) per share | Fiscal year 2021: $3.14 (loss) per share | Fiscal year 2020: $2.11 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: